Our structure

Our work is focused on five areas covering public affairs, regulatory affairs, influenza, access to vaccines, and research and development.

Executive board

Florence

Baron-Papillon

President (Sanofi)

Juan Carlos

Jaramillo

Vice-President (Valneva)

Andreas

Potthoff

(Abbott)

Hugo

Gomes da Silva

(AstraZeneca)

Sharon

McHale

(CSL Seqirus)

Guillermo

De Juan

(GSK)

Jürgen

Betzing

(IDT Biologika)

Jurgen

Kwik

(Janssen/JnJ)

Annick

Manuel

(Moderna)

Nicoletta

Luppi

(MSD)

Kelly

Cappio

(Novavax)

Deborah

Scarano

(Pfizer)

Logan

Rae

(Takeda)

Executive office

Sibilia

Quilici

Executive Director

Laurent

Louette

Director Public Affairs & Country Liaison

Anna

Czwarno

Director, Regulatory and R&D

Anna

Vicere

Senior Manager, Access Policy & Public Affairs

Polina

Zoteva

Communications Lead

Anne

Meynaerts

Administrative Assistant

Working Group Chairs

Research, Innovation & Medical

Manufacturing & Supply

Philippe

Juvin

Sanofi

National Vaccine Industry Group's Task Force

Renée

Gallo-Daniel

Pfizer